These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1418004)

  • 1. Treatment of systemic sclerosis with recombinant interferon-gamma. A phase I/II clinical trial.
    Freundlich B; Jimenez SA; Steen VD; Medsger TA; Szkolnicki M; Jaffe HS
    Arthritis Rheum; 1992 Oct; 35(10):1134-42. PubMed ID: 1418004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels.
    Polisson RP; Gilkeson GS; Pyun EH; Pisetsky DS; Smith EA; Simon LS
    J Rheumatol; 1996 Apr; 23(4):654-8. PubMed ID: 8730122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis.
    Vlachoyiannopoulos PG; Tsifetaki N; Dimitriou I; Galaris D; Papiris SA; Moutsopoulos HM
    Ann Rheum Dis; 1996 Oct; 55(10):761-8. PubMed ID: 8984943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-gamma in the treatment of systemic sclerosis: a randomized controlled multicentre trial.
    Grassegger A; Schuler G; Hessenberger G; Walder-Hantich B; Jabkowski J; MacHeiner W; Salmhofer W; Zahel B; Pinter G; Herold M; Klein G; Fritsch PO
    Br J Dermatol; 1998 Oct; 139(4):639-48. PubMed ID: 9892907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic scleroderma. Multicenter trial of 1 year of treatment with recombinant interferon gamma.
    Hunzelmann N; Anders S; Fierlbeck G; Hein R; Herrmann K; Albrecht M; Bell S; Thur J; Muche R; Adelmann-Grill B; Wehner-Caroli J; Gaus W; Krieg T
    Arch Dermatol; 1997 May; 133(5):609-13. PubMed ID: 9158414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant interferon-gamma in the treatment of systemic sclerosis.
    Kahan A; Amor B; Menkes CJ; Strauch G
    Am J Med; 1989 Sep; 87(3):273-7. PubMed ID: 2505614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of systemic sclerosis with gamma-interferon.
    Hein R; Behr J; Hündgen M; Hunzelmann N; Meurer M; Braun-Falco O; Urbanski A; Krieg T
    Br J Dermatol; 1992 May; 126(5):496-501. PubMed ID: 1610690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interferon gamma therapy for atopic dermatitis.
    Hanifin JM; Schneider LC; Leung DY; Ellis CN; Jaffe HS; Izu AE; Bucalo LR; Hirabayashi SE; Tofte SJ; Cantu-Gonzales G
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):189-97. PubMed ID: 8432915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.
    Khanna D; Clements PJ; Furst DE; Korn JH; Ellman M; Rothfield N; Wigley FM; Moreland LW; Silver R; Kim YH; Steen VD; Firestein GS; Kavanaugh AF; Weisman M; Mayes MD; Collier D; Csuka ME; Simms R; Merkel PA; Medsger TA; Sanders ME; Maranian P; Seibold JR;
    Arthritis Rheum; 2009 Apr; 60(4):1102-11. PubMed ID: 19333948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of systemic sclerosis with extracorporeal photochemotherapy. Results of a multicenter trial.
    Rook AH; Freundlich B; Jegasothy BV; Perez MI; Barr WG; Jimenez SA; Rietschel RL; Wintroub B; Kahaleh MB; Varga J
    Arch Dermatol; 1992 Mar; 128(3):337-46. PubMed ID: 1550365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The course of skin involvement in systemic sclerosis over three years in a trial of chlorambucil versus placebo.
    Clements P; Lachenbruch P; Furst D; Paulus H
    Arthritis Rheum; 1993 Nov; 36(11):1575-9. PubMed ID: 8240434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
    DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
    Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A short 2 week dose titration regimen reduces the severity of flu-like symptoms with initial interferon gamma-1b treatment.
    Devane JG; Martin ML; Matson MA
    Curr Med Res Opin; 2014 Jun; 30(6):1179-87. PubMed ID: 24576196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of progressive scleroderma with gamma-interferon].
    Mensing H
    Hautarzt; 1991 Jun; 42(6):380-3. PubMed ID: 1917461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferons and systemic sclerosis: correlation between interferon gamma and interferon-lambda 1 (IL-29).
    Dantas AT; Gonçalves SM; Pereira MC; de Almeida AR; Marques CD; Rego MJ; Pitta Ida R; Duarte AL; Pitta MG
    Autoimmunity; 2015; 48(7):429-33. PubMed ID: 26057401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.
    Pope JE; Bellamy N; Seibold JR; Baron M; Ellman M; Carette S; Smith CD; Chalmers IM; Hong P; O'Hanlon D; Kaminska E; Markland J; Sibley J; Catoggio L; Furst DE
    Arthritis Rheum; 2001 Jun; 44(6):1351-8. PubMed ID: 11407694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2.
    Antonelli A; Fallahi P; Ferrari SM; Giuggioli D; Colaci M; Di Domenicantonio A; Ferri C
    J Rheumatol; 2012 May; 39(5):979-85. PubMed ID: 22422499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eastern cooperative group trial of interferon gamma in metastatic melanoma: an innovative study design.
    Schiller JH; Pugh M; Kirkwood JM; Karp D; Larson M; Borden E
    Clin Cancer Res; 1996 Jan; 2(1):29-36. PubMed ID: 9816086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study.
    Milanés-Virelles MT; García-García I; Santos-Herrera Y; Valdés-Quintana M; Valenzuela-Silva CM; Jiménez-Madrigal G; Ramos-Gómez TI; Bello-Rivero I; Fernández-Olivera N; Sánchez-de la Osa RB; Rodríguez-Acosta C; González-Méndez L; Martínez-Sánchez G; López-Saura PA;
    BMC Infect Dis; 2008 Feb; 8():17. PubMed ID: 18267006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferon.
    Grem JL; McAtee N; Murphy RF; Balis FM; Cullen E; Chen AP; Hamilton JM; Steinberg SM; Quinn M; Sorensen JM; Arbuck SG; Lawrence D; Pang J; Allegra CJ
    Clin Cancer Res; 1997 Jul; 3(7):1125-34. PubMed ID: 9815792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.